These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16025439)

  • 1. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.
    Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow MZ
    Microsurgery; 2005; 25(5):415-22. PubMed ID: 16025439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II.
    Klimczak A; Agaoglu G; Carnevale KA; Siemionow M
    Ann Plast Surg; 2006 Oct; 57(4):422-30. PubMed ID: 16998336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
    Siemionow MZ; Klimczak A; Unal S
    Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of donor-specific chimerism and tolerance in composite tissue allografts under alphabeta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols.
    Ozer K; Izycki D; Zielinski M; Siemionow M
    Microsurgery; 2004; 24(3):248-54. PubMed ID: 15160385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of chimerism with graft size and revascularization in vascularized and nonvascularized skin allografts.
    Nasir S; Bozkurt M; Krokowicz L; Klimczak A; Siemionow M
    Ann Plast Surg; 2009 Apr; 62(4):430-8. PubMed ID: 19325352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients.
    Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M
    Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
    Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
    J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimerism induction in vascularized bone marrow transplants augmented with bone marrow cells.
    Arslan E; Klimczak A; Siemionow M
    Microsurgery; 2007; 27(3):190-9. PubMed ID: 17326192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method of bone marrow transplantation leads to extension of skin allograft survival.
    Siemionow M; Ozer K; Izycki D; Unsal M; Klimczak A
    Transplant Proc; 2005 Jun; 37(5):2309-14. PubMed ID: 15964406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants.
    Siemionow M; Demir Y; Mukherjee A; Klimczak A
    Transplantation; 2005 Mar; 79(5):558-67. PubMed ID: 15753845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation with anti-alphabeta T-cell receptor monoclonal antibodies in combination with cyclosporine A improves regeneration in nerve allografts.
    Scharpf J; Strome M; Siemionow M
    Microsurgery; 2006; 26(8):599-607. PubMed ID: 17066409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI; Cofer BR; Davies C; Alexander JW
    Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.
    Hivelin M; Klimczak A; Cwykiel J; Sonmez E; Nasir S; Gatherwright J; Siemionow M
    Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):299-310. PubMed ID: 26708158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tolerance in a rat model of laryngeal transplantation.
    Akst LM; Siemionow M; Dan O; Izycki D; Strome M
    Transplantation; 2003 Dec; 76(12):1763-70. PubMed ID: 14688529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.